Communiqués SkinBioTherapeutics plc

Actions

SBTX

GB00BF33H870

Recherche biotechnologique et médicale

Temps Différé London S.E. 15:36:48 24/09/2026			Varia. 5j.	Varia. 1 janv.
6,000 ^GBX	+4,35%		-31,43%	-61,90%

22/09	RÉSULTATS et TRADING : Aeorema relève ses prévisions ; ZCCM repasse dans le vert	AN
22/09	SkinBioTherapeutics plc publie des prévisions de résultats pour l’exercice 2026	CI

Communiqués

15/09/25	Celebrating our innovative ingredients: Zenakine™ – redefining neurocosmetic skincare possibilities	PU
19/12/22	SkinBioTherapeutics will "continue to be flexible enough to adapt to opportunities"	AQ
19/12/22	SkinBioTherapeutics will 'continue to be flexible enough to adapt to opportunities'	EQ
26/05/21	SkinBioTherapeutics : Positive data for AxisBiotix-Ps™ food supplement consumer study unveiled	PU
27/04/21	SkinBioTherapeutics : Initiation of oral health development programme \| 27 April 2021» Click here to view website page / read more	PU
27/04/21	SkinBioTherapeutics : New oral health research programme initiated with the University of Manchester	PU
27/04/21	SkinBioTherapeutics : New research agreement initiated with the University of Manchester	PU
08/04/21	SkinBioTherapeutics : Research programme with University of Manchester \| 08 April 2021» Click here to view website page / read more	PU
03/03/20	SkinBioTherapeutics : Half Year Results	PU
19/02/20	SkinBioTherapeutics : signs agreement with Winclove Probiotics to develop psoriasis food supplement	PU
20/11/19	SkinBioTherapeutics : announces a Commercial & Manufacturing Agreement with Speciality Chemical Company, Croda Plc	PU
28/08/19	Skinbiotherapeutics : Second Price Monitoring Extn	PU
28/08/19	Skinbiotherapeutics : Price Monitoring Extension	PU
04/07/19	Skinbiotherapeutics : Business Update and Board Changes	PU
25/06/19	Skinbiotherapeutics : Our skin is crawling with bacteria - and that's good news	PU
18/04/19	Skinbiotherapeutics : Director Appointment	PU
16/04/19	Skinbiotherapeutics : Director Dealing	PU
08/04/19	Skinbiotherapeutics : SkinBiotix® shows efficacy in first human study	PU
08/04/19	Skinbiotherapeutics : SkinBiotix shows efficacy in first human study	PU
29/03/19	Skinbiotherapeutics : CEO Designate Appointment	PU
20/11/18	Skinbiotherapeutics : Commencement of final phase of human studies	PU
07/11/18	Skinbiotherapeutics : SkinBiotix® technology generates positive data in first two elements of its human study	PU
07/11/18	Skinbiotherapeutics : SkinBiotix? generates positive data in human study	PU
25/10/18	Skinbiotherapeutics : Full year results	PU
19/09/18	Skinbiotherapeutics : Human study commenced	PU